apomorphine [Ligand Id: 33] activity data from GtoPdb and ChEMBL

Click here for a description of the charts and data table

Please tell us if you are using this feature and what you think!

ChEMBL ligand: CHEMBL53 (Apomorphine, VR040, APL-130277, VR-040)
  • D1 receptor/Dopamine D1 receptor in Human [ChEMBL: CHEMBL2056] [GtoPdb: 214] [UniProtKB: P21728]
  • D1 receptor/Dopamine D1 receptor in Mouse [ChEMBL: CHEMBL3071] [GtoPdb: 214] [UniProtKB: Q61616]
  • D1 receptor/Dopamine D1 receptor in Rat [ChEMBL: CHEMBL265] [GtoPdb: 214] [UniProtKB: P18901]
1 CHEMBL53_lig_chart_1 Dopamine D1 receptor HumanMouseRat
There should be some charts here, you may need to enable JavaScript!
  • D2 receptor/Dopamine D2 receptor in Human [ChEMBL: CHEMBL217] [GtoPdb: 215] [UniProtKB: P14416]
  • Dopamine D2 receptor in Bovine [ChEMBL: CHEMBL3998] [UniProtKB: P20288]
  • D2 receptor/Dopamine D2 receptor in Rat [ChEMBL: CHEMBL339] [GtoPdb: 215] [UniProtKB: P61169]
2 CHEMBL53_lig_chart_2 Dopamine D2 receptor HumanBovineRat
There should be some charts here, you may need to enable JavaScript!
  • D3 receptor/Dopamine D3 receptor in Human [ChEMBL: CHEMBL234] [GtoPdb: 216] [UniProtKB: P35462]
  • D3 receptor/Dopamine D3 receptor in Rat [ChEMBL: CHEMBL3138] [GtoPdb: 216] [UniProtKB: P19020]
3 CHEMBL53_lig_chart_3 Dopamine D3 receptor HumanRat
There should be some charts here, you may need to enable JavaScript!
  • D4 receptor/Dopamine D4 receptor in Human [ChEMBL: CHEMBL219] [GtoPdb: 217] [UniProtKB: P21917]
  • D4 receptor/Dopamine D4 receptor in Rat [ChEMBL: CHEMBL3361] [GtoPdb: 217] [UniProtKB: P30729]
4 CHEMBL53_lig_chart_4 Dopamine D4 receptor HumanRat
There should be some charts here, you may need to enable JavaScript!
  • MDM2 proto-oncogene/p53-binding protein Mdm-2 in Human [ChEMBL: CHEMBL5023] [GtoPdb: 3136] [UniProtKB: Q00987]
  • This target only has 0 pki data point
5 CHEMBL53_lig_chart_5 p53-binding protein Mdm-2 Human
There should be some charts here, you may need to enable JavaScript!
  • 5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Human [ChEMBL: CHEMBL214] [GtoPdb: 1] [UniProtKB: P08908]
  • 5-HT1A receptor/Serotonin 1a (5-HT1a) receptor in Rat [ChEMBL: CHEMBL273] [GtoPdb: 1] [UniProtKB: P19327]
6 CHEMBL53_lig_chart_6 Serotonin 1a (5-HT1a) receptor HumanRat
There should be some charts here, you may need to enable JavaScript!
  • 5-HT7 receptor/Serotonin 7 (5-HT7) receptor in Rat [ChEMBL: CHEMBL3223] [GtoPdb: 12] [UniProtKB: P32305]
7 CHEMBL53_lig_chart_7 Serotonin 7 (5-HT7) receptor Rat
There should be some charts here, you may need to enable JavaScript!
  • sigma non-opioid intracellular receptor 1/Sigma opioid receptor in Human [ChEMBL: CHEMBL287] [GtoPdb: 2552] [UniProtKB: Q99720]
  • sigma non-opioid intracellular receptor 1/Sigma opioid receptor in Rat [ChEMBL: CHEMBL3602] [GtoPdb: 2552] [UniProtKB: Q9R0C9]
  • This target only has 0 pki data point
8 CHEMBL53_lig_chart_8 Sigma opioid receptor HumanRat
There should be some charts here, you may need to enable JavaScript!
  • Organic cation transporter 1/Solute carrier family 22 member 1 in Human [ChEMBL: CHEMBL5685] [GtoPdb: 1019] [UniProtKB: O15245]
  • This target only has 0 pki data point
9 CHEMBL53_lig_chart_9 Solute carrier family 22 member 1 Human
There should be some charts here, you may need to enable JavaScript!
  • 5-HT2A receptor in Human [GtoPdb: 6] [UniProtKB: P28223]
  • This target only has 1 pki data point
10 CHEMBL53_lig_chart_10 5-HT2A receptor Human
There should be some charts here, you may need to enable JavaScript!
  • 5-HT2B receptor in Human [GtoPdb: 7] [UniProtKB: P41595]
  • This target only has 1 pki data point
11 CHEMBL53_lig_chart_11 5-HT2B receptor Human
There should be some charts here, you may need to enable JavaScript!
  • 5-HT2C receptor in Human [GtoPdb: 8] [UniProtKB: P28335]
  • This target only has 1 pki data point
12 CHEMBL53_lig_chart_12 5-HT2C receptor Human
There should be some charts here, you may need to enable JavaScript!
  • α2A-adrenoceptor in Human [GtoPdb: 25] [UniProtKB: P08913]
  • This target only has 1 pki data point
13 CHEMBL53_lig_chart_13 α2A-adrenoceptor Human
There should be some charts here, you may need to enable JavaScript!
  • α2B-adrenoceptor in Human [GtoPdb: 26] [UniProtKB: P18089]
  • This target only has 1 pki data point
14 CHEMBL53_lig_chart_14 α2B-adrenoceptor Human
There should be some charts here, you may need to enable JavaScript!
  • α2C-adrenoceptor in Human [GtoPdb: 27] [UniProtKB: P18825]
  • This target only has 1 pki data point
15 CHEMBL53_lig_chart_15 α2C-adrenoceptor Human
There should be some charts here, you may need to enable JavaScript!
  • D5 receptor in Human [GtoPdb: 218] [UniProtKB: P21918]
  • This target only has 1 pki data point
16 CHEMBL53_lig_chart_16 D5 receptor Human
There should be some charts here, you may need to enable JavaScript!
  • TRPA1 in Human [GtoPdb: 485] [UniProtKB: O75762]
  • This target only has 0 pki data point
17 CHEMBL53_lig_chart_17 TRPA1 Human
There should be some charts here, you may need to enable JavaScript!
DB Assay description Assay Type Standard value Standard parameter Original value Original units Original parameter Reference
D1 receptor/Dopamine D1 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2056] [GtoPdb: 214] [UniProtKB: P21728]
ChEMBL Equilibrium dissociation constant against recombinant Dopamine receptor D1A expressed in COS7 cells B 6.17 pKd 680 nM Kd J. Med. Chem. (1996) 39: 850-859 [PMID:8632409]
ChEMBL Displacement of [3H]SCH23390 from human D1 receptor expressed in HEK293 cells B 6.18 pKi 660 nM Ki Eur. J. Med. Chem. (2012) 55: 255-261 [PMID:22846798]
ChEMBL Binding affinity to dopamine D1 receptor low binding site by radioligand displacement assay B 6.19 pKi 650 nM Ki ACS Med. Chem. Lett. (2011) 2: 189-194 [PMID:21666830]
GtoPdb - - 6.2 pKi - - - Nature (1991) 350: 614-9 [PMID:1826762];
J. Biol. Chem. (1994) 269: 27925-31 [PMID:7525564]
ChEMBL Displacement of [3H]SCH23390 from human dopamine D1 receptor expressed in HEK293 cells by scintillation counting analysis B 6.31 pKi 492 nM Ki Bioorg. Med. Chem. (2013) 21: 4143-4150 [PMID:23727194]
ChEMBL Displacement of [3H]SCH-23390 from human dopamine D1 receptor expressed in HEK293 cells B 6.54 pKi 290 nM Ki Bioorg. Med. Chem. (2008) 16: 6675-6681 [PMID:18562201]
ChEMBL Displacement of [3H]SCH23390 from dopamine D1 receptor expressed in Ltk deficient fibroblast cells by liquid scintillation counting B 7.14 pKi 72 nM Ki Bioorg. Med. Chem. (2009) 17: 4756-4762 [PMID:19454369]
ChEMBL Displacement of [3H]SCH23390 from human D1 dopamine receptor expressed in Ltk fibroblast cells after 60 mins by liquid scintillation counter B 7.14 pKi 72 nM Ki Eur. J. Med. Chem. (2011) 46: 2992-2999 [PMID:21550699]
ChEMBL Binding affinity to dopamine D1 receptor high binding site by radioligand displacement assay B 8.34 pKi 4.6 nM Ki ACS Med. Chem. Lett. (2011) 2: 189-194 [PMID:21666830]
ChEMBL Agonist activity at human recombinant dopamine D1 receptor expressed in CHO cells assessed as stimulation of cAMP production F 7.28 pEC50 52 nM EC50 Bioorg. Med. Chem. (2008) 16: 3438-3444 [PMID:18313303]
ChEMBL Agonist activity at human dopamine D1 receptor expressed in HEK293 cells assessed as cAMP accumulation after 15 mins F 7.59 pEC50 25.7 nM EC50 Bioorg. Med. Chem. (2013) 21: 4143-4150 [PMID:23727194]
D1 receptor/Dopamine D1 receptor in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3071] [GtoPdb: 214] [UniProtKB: Q61616]
ChEMBL Displacement of [3H]SCH23390 from dopamine D1 receptor in mouse Ltk- fibroblast cells B 7 pKi 101 nM Ki Bioorg. Med. Chem. (2008) 16: 4563-4568 [PMID:18313931]
D1 receptor/Dopamine D1 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL265] [GtoPdb: 214] [UniProtKB: P18901]
ChEMBL Displacement of [3H]SCH-23390 from dopamine D1 receptor in rat striatum B 6 pKi 1010 nM Ki J. Med. Chem. (2008) 51: 983-987 [PMID:18251489]
ChEMBL In vitro binding affinity towards Dopamine receptor D1 by displacing [125I]FISCH radioligand in rat striatal homogenate B 6.05 pKi 888 nM Ki J. Med. Chem. (1989) 32: 1431-1435 [PMID:2525621]
ChEMBL In vitro displacement of [3H]SCH-23390 binding to rat striatal Dopamine receptor D1 B 6.63 pKi 236 nM Ki J. Med. Chem. (1996) 39: 3503-3513 [PMID:8784448]
ChEMBL In vitro affinity at Dopamine receptor D1 of rat striatum by [3H]SCH-23390 displacement. B 6.63 pKi 236 nM Ki J. Med. Chem. (1996) 39: 3491-3502 [PMID:8784447]
ChEMBL Ability to displace [3H]SCH-23390 binding to rat striatal Dopamine receptor D1 B 6.63 pKi 236 nM Ki J. Med. Chem. (1995) 38: 647-658 [PMID:7861413]
ChEMBL Binding affinity at rat striatal Dopamine receptor D1 using [3H]- SCH-23390 radioligand B 6.63 pKi 236 nM Ki J. Med. Chem. (1990) 33: 1800-1805 [PMID:1971309]
ChEMBL Tested for binding affinity towards rat striatal dopamine receptor D1 using [3H]-SCH- 23390 as radioligand B 6.66 pKi >221 nM Ki J. Med. Chem. (1994) 37: 3523-3533 [PMID:7932581]
ChEMBL Displacement of [3H]SCH-23390 from rat dopamine D1 receptor B 6.68 pKi 210 nM Ki J. Med. Chem. (2007) 50: 171-181 [PMID:17228858]
ChEMBL Binding Affinity was determined against Dopamine receptor D1 in rat striatal membranes using [3H]- SCH 23390 radioligand. B 6.74 pKi 181.97 nM Ki J. Med. Chem. (2000) 43: 599-608 [PMID:10691686]
ChEMBL Displacement of [3H]fenoldopam from Dopamine receptor D1 of rat striatum membranes B 7.28 pKi 53 nM Ki J. Med. Chem. (1986) 29: 1904-1912 [PMID:3761310]
ChEMBL Compound was evaluated for the inhibition of [3H]-SCH- 23390 binding to Dopamine receptor D1 of rat striatal membranes B 5.52 pIC50 3000 nM IC50 J. Med. Chem. (1990) 33: 2408-2412 [PMID:1975274]
ChEMBL Binding affinity against Dopamine receptor D1 from rat brain corpus striatum membrane B 6.35 pIC50 444 nM IC50 J. Med. Chem. (1990) 33: 3122-3124 [PMID:2147956]
ChEMBL In vitro binding affinity towards rat Dopamine receptor D1 by [3H]SCH-23390 displacement. B 6.36 pIC50 432 nM IC50 J. Med. Chem. (1990) 33: 600-607 [PMID:2405158]
ChEMBL Inhibition of binding of [3H]SCH-23390 to Dopamine receptor D1 in rat striatal membranes B 6.37 pIC50 430 nM IC50 Bioorg. Med. Chem. Lett. (2001) 11: 883-886 [PMID:11294383]
ChEMBL Inhibition of binding of [3H]SCH-23390 to Dopamine receptor D1 was determined B 6.42 pIC50 384 nM IC50 J. Med. Chem. (1990) 33: 311-317 [PMID:1967314]
ChEMBL In vitro binding affinity to Dopamine receptor D1 in rat striatal membranes using D1 antagonist [3H]SCH-23390 B 6.42 pIC50 384 nM IC50 Bioorg. Med. Chem. Lett. (1991) 1: 539-544
ChEMBL Affinity of the Compound for Dopamine D1 receptor in rat striatal membrane was determined in vitro using Dopamine Antagonist [3H]SCH-23390 as ligand. F 6.42 pIC50 384 nM IC50 Bioorg. Med. Chem. Lett. (1991) 1: 189-192
ChEMBL Compound was tested in vitro for binding affinity towards Dopamine receptor D1 in rat striatal membrane by using [3H]-SCH- 23390 as radioligand B 6.42 pIC50 384 nM IC50 J. Med. Chem. (1991) 34: 2736-2746 [PMID:1680195]
ChEMBL In vitro antagonist binding affinity was determined by displacing the [3H]-SCH- in rat striatal Dopamine receptor D1 B 6.62 pIC50 238 nM IC50 Bioorg. Med. Chem. Lett. (1993) 3: 639-644
D2 receptor/Dopamine D2 receptor in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL217] [GtoPdb: 215] [UniProtKB: P14416]
ChEMBL Compound was evaluated for the ability to displace [3H]spiperone at Dopamine receptor D2 in porcine anterior pituitary gland as low affinity state B 6.9 pKd 127 nM Kd J. Med. Chem. (1989) 32: 1198-1201 [PMID:2524592]
ChEMBL Equilibrium dissociation constant against recombinant Dopamine receptor D2A expressed in COS7 cells B 7.62 pKd 24 nM Kd J. Med. Chem. (1996) 39: 850-859 [PMID:8632409]
ChEMBL Compound was evaluated for the ability to displace [3H]spiperone at Dopamine receptor D2 in porcine anterior pituitary gland as high affinity state B 9.18 pKd 0.66 nM Kd J. Med. Chem. (1989) 32: 1198-1201 [PMID:2524592]
ChEMBL Displacement of [3H]spiperone from human dopamine D2 receptor at low affinity state expressed in HEK293 cells B 6.61 pKi 244 nM Ki J. Med. Chem. (2010) 53: 2510-2520 [PMID:20155917]
ChEMBL Tested for affinity against cloned mammalian dopamine autoreceptor (DA) D2 receptors expressed in CHO-K1 cells using [3H]spiperone as radioligand B 6.66 pKi >217 nM Ki J. Med. Chem. (1994) 37: 2735-2753 [PMID:8064801]
ChEMBL Displacement of [3H]spiperone from human dopamine D2 receptor expressed in HEK293 cells B 7.01 pKi 98 nM Ki Bioorg. Med. Chem. (2008) 16: 6675-6681 [PMID:18562201]
ChEMBL Displacement of [3H]raclopride from human dopamine D2L receptor expressed in HEK293 cells by scintillation counting analysis B 7.28 pKi 53 nM Ki Bioorg. Med. Chem. (2013) 21: 4143-4150 [PMID:23727194]
ChEMBL Displacement of [3H]raclopride from human D2L receptor expressed in HEK293 cells B 7.3 pKi 50 nM Ki Eur. J. Med. Chem. (2012) 55: 255-261 [PMID:22846798]
ChEMBL Displacement of [3H]raclopride from human dopamine receptor D2A expressed in mouse Ltk cells B 7.38 pKi 41.9 nM Ki J. Med. Chem. (2001) 44: 1337-1340 [PMID:11311055]
ChEMBL Ability to displace [3H]raclopride binding to cloned human Dopamine receptor D2A B 7.38 pKi 41.9 nM Ki J. Med. Chem. (1995) 38: 647-658 [PMID:7861413]
ChEMBL Displacement of [3H]raclopride from human Dopamine receptor D2A B 7.38 pKi 41.9 nM Ki J. Med. Chem. (1996) 39: 3503-3513 [PMID:8784448]
ChEMBL In vitro affinity at human cloned Dopamine receptor D2A by [3H]-raclopride displacement. B 7.38 pKi 41.9 nM Ki J. Med. Chem. (1996) 39: 3491-3502 [PMID:8784447]
ChEMBL Binding affinity was measured on cloned Human D2A Receptor which is labeled by [3H]raclopride B 7.38 pKi 41.6 nM Ki J. Med. Chem. (2000) 43: 1339-1349 [PMID:10753471]
ChEMBL In vitro binding affinity towards cloned human Dopamine receptor D2A using [3H]- Raclopride as radioligand. B 7.38 pKi 41.6 nM Ki Bioorg. Med. Chem. Lett. (2001) 11: 367-370 [PMID:11212112]
ChEMBL Displacement of [3H]raclopride from human cloned dopamine D2 receptor expressed in CHO cell membrane B 7.49 pKi 32 nM Ki Bioorg. Med. Chem. (2008) 16: 4563-4568 [PMID:18313931]
GtoPdb - - 7.5 pKi - - - J. Pharmacol. Exp. Ther. (2002) 303: 791-804 [PMID:12388666];
J. Pharmacol. Exp. Ther. (1994) 268: 417-26 [PMID:8301582];
Neuroreport (1995) 6: 329-332 [PMID:7756621];
Neuropsychopharmacology (1995) 12: 335-45 [PMID:7576010];
Eur. J. Pharmacol. (1992) 225: 331-7 [PMID:1354163]
ChEMBL Tested for binding affinity towards human D2L receptor using [3H]spiperone as radioligand B 7.55 pKi 28 nM Ki J. Med. Chem. (1994) 37: 3523-3533 [PMID:7932581]
ChEMBL Compound was evaluated for the binding affinity against [3H]U-86,170-labeled D2 sites in cloned CHO cells B 7.59 pKi 26 nM Ki J. Med. Chem. (1993) 36: 1053-1068 [PMID:8097537]
ChEMBL Compound was evaluated for the binding affinity against [3H]U-86,170-labeled D2 sites in cloned CHO cells B 7.59 pKi 26 nM Ki J. Med. Chem. (1993) 36: 1069-1083 [PMID:8097538]
ChEMBL Displacement of [125I]7-OH-PIPAT from human D2L receptor expressed in HEK293 cell membrane B 8.44 pKi 3.6 nM Ki J. Med. Chem. (2006) 49: 7450-7465 [PMID:17149874]
ChEMBL Displacement of [3H]spiperone from human dopamine D2 receptor at high affinity state expressed in HEK293 cells B 9.21 pKi 0.62 nM Ki J. Med. Chem. (2010) 53: 2510-2520 [PMID:20155917]
ChEMBL Displacement of [3H]spiperone from human recombinant dopamine D2L receptor expressed in CHOFlpIn cells after 3 hrs by liquid scintillation counting B 6.93 pIC50 117 nM IC50 MedChemComm (2013) 4: 1290-1296
ChEMBL Agonist activity at human dopamine D2 receptor expressed in CHOK1 cells assessed as calcium mobilization by radiometric and luminescence plate counting method F 8.38 pIC50 4.2 nM IC50 Eur. J. Med. Chem. (2015) 92: 221-235 [PMID:25557493]
ChEMBL Agonist activity at dopamine D2 receptor short isoform (unknown origin) expressed in mouse NIH/3T3 cells by R-SAT assay B 6.24 pEC50 575.44 nM EC50 US-20040213816-A1. Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases (2004)
ChEMBL Agonist activity at human recombinant dopamine D2 receptor expressed in rat pituitary cells assessed as inhibition of forskolin-stimulated cAMP accumulation F 7.7 pEC50 20 nM EC50 Bioorg. Med. Chem. Lett. (2007) 17: 6691-6696 [PMID:17976986]
ChEMBL Agonist activity at human D2 receptor expressed in CHO-K1 cells co-expressing Galphaqi5 assessed as increase in calcium mobilization measured for 30 secs by aequorin-derived luminescence assay F 7.9 pEC50 12.7 nM EC50 Bioorg Med Chem Lett (2018) 28: 2039-2049 [PMID:29730027]
ChEMBL In vitro effective concentration tested on HEK293 cells co-transfected with human Dopamine receptor D2 using FLIPR assay B 8.24 pEC50 5.8 nM EC50 J. Med. Chem. (2004) 47: 3853-3864 [PMID:15239663]
ChEMBL Agonist activity at human D2 receptor in HEK293 cells coexpressing G-alpha-qo5 by FLIPR F 8.24 pEC50 5.8 nM EC50 J. Med. Chem. (2006) 49: 7450-7465 [PMID:17149874]
ChEMBL Agonist activity at human dopamine D2L receptor expressed in HEK293 cells assessed as forskolin-stimulated cAMP accumulation after 15 mins F 8.4 pEC50 4 nM EC50 Bioorg. Med. Chem. (2013) 21: 4143-4150 [PMID:23727194]
ChEMBL Agonist activity at human dopamine D2 receptor expressed in CHO cells assessed as inhibition of forskolin-stimulated cAMP production F 8.4 pEC50 4 nM EC50 Bioorg. Med. Chem. (2008) 16: 3438-3444 [PMID:18313303]
ChEMBL Agonist activity at ferret D2 receptor in HEK293 cells coexpressing Galphaqo5 by FLIPR F 8.74 pEC50 1.8 nM EC50 J. Med. Chem. (2006) 49: 7450-7465 [PMID:17149874]
ChEMBL Agonist activity at human recombinant dopamine D2L receptor expressed in CHOFlpIn cells assessed as ERK1/2 phosphorylation by alphascreen assay B 8.77 pEC50 1.7 nM EC50 MedChemComm (2013) 4: 1290-1296
Dopamine D2 receptor in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3998] [UniProtKB: P20288]
ChEMBL Compound was tested for inhibition of [3H]spiroperidol binding against Dopamine receptor D2 B 6.7 pKi 200 nM Ki J. Med. Chem. (1986) 29: 1904-1912 [PMID:3761310]
D2 receptor/Dopamine D2 receptor in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL339] [GtoPdb: 215] [UniProtKB: P61169]
ChEMBL In vitro affinity at mutant D2 receptor (S194A) in C6 (glioma) cell membranes. B 5.8 pKd 1600 nM Kd J. Med. Chem. (2000) 43: 3005-3019 [PMID:10956209]
ChEMBL In vitro affinity at mutant D2 receptor (S194A) in C6 (glioma) cell membranes. B 5.92 pKd 1200 nM Kd J. Med. Chem. (2000) 43: 3005-3019 [PMID:10956209]
ChEMBL In vitro affinity at mutant D2 receptor (S197A) in C6 (glioma) cell membranes. B 6.22 pKd 600 nM Kd J. Med. Chem. (2000) 43: 3005-3019 [PMID:10956209]
ChEMBL In vitro affinity at wild type Dopamine receptor D2 on C6 (glioma) cell membranes. B 6.7 pKd 200 nM Kd J. Med. Chem. (2000) 43: 3005-3019 [PMID:10956209]
ChEMBL Displacement of [3H]SCH23390 from dopamine D2 receptor low binding site in Sprague-Dawley rat striatum by scintillation counting B 7.01 pKi 98 nM Ki ACS Med. Chem. Lett. (2011) 2: 189-194 [PMID:21666830]
ChEMBL Binding Affinity was determined against Dopamine receptor D2 in rat striatal membranes using [3H]- spiperone radioligand. B 7.26 pKi 54.95 nM Ki J. Med. Chem. (2000) 43: 599-608 [PMID:10691686]
ChEMBL Ability to displace [3H]raclopride from dopamine receptor D2 in rat striatal homogenates. B 7.34 pKi 46 nM Ki J. Med. Chem. (1992) 35: 1076-1092 [PMID:1348089]
ChEMBL Displacement of [3H]raclopride from rat dopamine D2(short) receptor expressed in CHOK1 cells B 7.49 pKi 32 nM Ki Bioorg. Med. Chem. (2008) 16: 4563-4568 [PMID:18313931]
GtoPdb - - 7.6 pKi - - - Nature (1990) 347: 146-51 [PMID:1975644]
ChEMBL Tested for binding affinity towards rat striatal D2 receptor using [3H]spiperone as radioligand B 7.76 pKi 17.3 nM Ki J. Med. Chem. (1994) 37: 3523-3533 [PMID:7932581]
ChEMBL Displacement of [3H]raclopride from rat dopamine D2 receptor B 7.89 pKi 13 nM Ki J. Med. Chem. (2007) 50: 171-181 [PMID:17228858]
ChEMBL Displacement of [3H]raclopride from rat D2 dopamine receptor expressed in CHOK1 cells after 90 mins by liquid scintillation counter scintillation counter B 7.94 pKi 11.5 nM Ki Eur. J. Med. Chem. (2011) 46: 2992-2999 [PMID:21550699]
ChEMBL Displacement of [3H]raclopride from rat dopamine D2short receptor expressed in CHO-K1 cells by liquid scintillation counting B 7.94 pKi 11.5 nM Ki Bioorg. Med. Chem. (2009) 17: 4756-4762 [PMID:19454369]
ChEMBL Binding affinity at rat striatal Dopamine receptor D2 using [3H]- piperone radioligand B 7.95 pKi 11.1 nM Ki J. Med. Chem. (1990) 33: 1800-1805 [PMID:1971309]
ChEMBL Displacement of [3H]raclopride from dopamine D2 receptor in rat striatal membrane B 7.95 pKi 11.1 nM Ki Bioorg. Med. Chem. (2008) 16: 4563-4568 [PMID:18313931]
ChEMBL Tested for binding affinity towards rat striatal D2 receptor using [3H]NPA as radioligand B 8.66 pKi 2.2 nM Ki J. Med. Chem. (1994) 37: 3523-3533 [PMID:7932581]
ChEMBL Displacement of [3H]neomonapride from dopamine D2 receptor in rat striatum B 8.72 pKi 1.9 nM Ki J. Med. Chem. (2008) 51: 983-987 [PMID:18251489]
ChEMBL Displacement of [3H]domperidone from dopamine D2 receptor high binding site in Sprague-Dawley rat striatum by scintillation counting B 8.74 pKi 1.8 nM Ki ACS Med. Chem. Lett. (2011) 2: 189-194 [PMID:21666830]
ChEMBL Neuroleptic activity in terms of [3H]spiroperidol binding in rat striatal membrane to Dopamine receptor D2 B 6.52 pIC50 302 nM IC50 J. Med. Chem. (1991) 34: 194-197 [PMID:1671414]
ChEMBL Inhibition of binding of [3H]spiroperidol to Dopamine receptor D2 in rat striatal membranes B 6.66 pIC50 220 nM IC50 Bioorg. Med. Chem. Lett. (2001) 11: 883-886 [PMID:11294383]
ChEMBL Displacement of [3H]nemonapride from Rattus norvegicus (rat) chimeric dopamine D2 trunk/D2 tail receptor transfected in african green monkey COS7 cells after 1 hr by beta scintillation counting B 6.87 pIC50 135 nM IC50 Med Chem Res (2004) 13: 25-33
ChEMBL Displacement of [3H]nemonapride from Rattus norvegicus (rat) wild type dopamine D2 receptor transfected in african green monkey COS7 cells after 1 hr by beta scintillation counting B 6.93 pIC50 118 nM IC50 Med Chem Res (2004) 13: 25-33
ChEMBL Compound was evaluated for the inhibition of [3H]spiperone binding to Dopamine receptor D2 of rat striatal membranes B 7.15 pIC50 70 nM IC50 J. Med. Chem. (1990) 33: 2408-2412 [PMID:1975274]
ChEMBL Binding affinity against Dopamine receptor D2 from rat brain corpus striatum membrane B 7.18 pIC50 66.7 nM IC50 J. Med. Chem. (1990) 33: 3122-3124 [PMID:2147956]
ChEMBL Inhibition of [3H]haloperidol binding for Dopamine receptor D2 in rat striatal membranes. B 7.57 pIC50 27 nM IC50 J. Med. Chem. (1990) 33: 311-317 [PMID:1967314]
ChEMBL Concentration inhibiting specific binding of [3H]haloperidol to Dopamine receptor D2 from rat striatal brain. B 7.57 pIC50 27 nM IC50 J. Med. Chem. (1990) 33: 445-450 [PMID:1967318]
ChEMBL In vitro binding affinity to Dopamine receptor D2 in rat striatal membranes using D2 antagonist [3H]spiperone B 7.62 pIC50 24.1 nM IC50 Bioorg. Med. Chem. Lett. (1991) 1: 539-544
ChEMBL Affinity of the Compound for Dopamine receptor D2 in rat striatal membrane was determined in vitro using Dopamine Antagonist [3H]-spiperone as ligand; Value ranges from (20-29) F 7.62 pIC50 24.1 nM IC50 Bioorg. Med. Chem. Lett. (1991) 1: 189-192
ChEMBL Displacement of [3H]spiperone from rat striatal Dopamine receptor D2 B 7.62 pIC50 24 nM IC50 Bioorg. Med. Chem. Lett. (1993) 3: 639-644
ChEMBL Compound was tested in vitro for binding affinity towards Dopamine receptor D2 in rat striatal membrane by using [3H]spiperone as radioligand B 7.62 pIC50 24 nM IC50 J. Med. Chem. (1991) 34: 2736-2746 [PMID:1680195]
ChEMBL In vitro binding affinity towards rat Dopamine receptor D2 by [3H]spiperone displacement. B 7.68 pIC50 21 nM IC50 J. Med. Chem. (1990) 33: 600-607 [PMID:2405158]
ChEMBL Inhibitory concentration against radioligand [3H](-)-sulpiride binding to Dopamine receptor D2 in rat B 8.29 pIC50 5.1 nM IC50 J. Med. Chem. (1999) 42: 1076-1087 [PMID:10090790]
ChEMBL Inhibition of [3H]N-propylnorapomorphine as radioligand for Dopamine receptor D2 in rat striatal membranes B 8.59 pIC50 2.6 nM IC50 J. Med. Chem. (1990) 33: 311-317 [PMID:1967314]
ChEMBL Affinity for [3H]N-propylnorapomorphine (NPA) Dopamine receptor D2 B 8.59 pIC50 2.6 nM IC50 J. Med. Chem. (1990) 33: 445-450 [PMID:1967318]
ChEMBL In vitro agonist binding affinity was determined by displacing the [3H]N-propylnorapomorphine ([3H]NPA) in rat striatal Dopamine receptor D2 B </